Literature DB >> 18991476

Medicare Part D's effects on elderly patients' drug costs and utilization.

Jonathan D Ketcham1, Kosali I Simon.   

Abstract

OBJECTIVE: To analyze Medicare Part D's net effect on elderly patients' use of and out-of-pocket (OOP) costs for prescription drugs and to compare these with standardized results from prior studies. STUDY
DESIGN: Our dataset contains 1.4 billion prescriptions from Wolters Kluwer Health from December 2004 through December 2007 for patients whose age as of 2007 was more than 57 years.
METHODS: Days' supply per capita, OOP cost per day's supply, and number of individuals filling prescriptions were compared before and after January 2006 for those over age 66 years versus those age 58-64 years. Adjustment was made for under-reporting of pure cash prescriptions in the data.
RESULTS: Elderly patients' utilization in the first year of Part D increased compared with that of near-elderly patients by 8.1% for days' supply and 4.8% for the number of individuals filling prescriptions, and their OOP costs declined by 17.2%. Although elderly patients' OOP costs in the second year were reduced an additional 5.8%, days' supply increased by only an additional 1.0%. Correcting for the under-reporting of pure cash prescriptions yielded effects of 8.1% and -3.5% for days' supply and -15.6% and -7.2% for OOP costs in 2006 and 2007, respectively. A standardized comparison with previous estimates from Walgreens data showed that our utilization estimates were 2.6 times larger.
CONCLUSION: Part D lowered elderly patients' OOP costs and increased utilization, primarily during the first year of the program. Magnitudes vary substantially across studies because of differences in data and methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991476

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  26 in total

Review 1.  The Economic Promise of Delayed Aging.

Authors:  Dana Goldman
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

2.  Insurers' Negotiating Leverage and the External Effects of Medicare Part D.

Authors:  Darius Lakdawalla; Wesley Yin
Journal:  Rev Econ Stat       Date:  2015-05-01

3.  How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries.

Authors:  Yuting Zhang; Judith R Lave; Joseph P Newhouse; Julie M Donohue
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-12-14       Impact factor: 4.077

4.  Caution in generalizing Part D results to Medicare population.

Authors:  Becky A Briesacher; Jeanne M Madden; Stephen B Soumerai
Journal:  Arch Intern Med       Date:  2011-02-28

5.  The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility.

Authors:  Frank Xiaoqing Liu; G Caleb Alexander; Stephanie Y Crawford; A Simon Pickard; Donald Hedeker; Surrey M Walton
Journal:  Health Serv Res       Date:  2011-05-24       Impact factor: 3.402

6.  Receipt of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers among Medicare Beneficiaries with Diabetes and Hypertension.

Authors:  Junling Wang; Satya Surbhi; Julie W Kuhle
Journal:  J Pharm Health Serv Res       Date:  2014-03-01

7.  Prescription drug coverage and chronic pain.

Authors:  Padmaja Ayyagari
Journal:  Int J Health Econ Manag       Date:  2016-01-30

8.  Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.

Authors:  Liran Einav; Amy Finkelstein; Maria Polyakova
Journal:  Am Econ J Econ Policy       Date:  2018-08

9.  Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications.

Authors:  Pinar Karaca-Mandic; Tami Swenson; Jean M Abraham; Robert L Kane
Journal:  Health Serv Res       Date:  2012-12-26       Impact factor: 3.402

10.  Impact of Medicare Part D on Racial and Ethnic Minorities.

Authors:  JoEllen Jarrett Jamison; Junling Wang; Satya Surbhi; Samantha Adams; David Solomon; Kenneth C Hohmeier; Sharon McDonough; James C Eoff
Journal:  Divers Equal Health Care       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.